RSS   Newsletter   Contact   Advertise with us
Post Online Media

PGDx adds James Lewis as SVP, corporate development

PGDxPersonal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome testing products and services, announced that James Lewis has joined the company as senior vice president of corporate development.
Article continues below

READ MORE Feihe International appoints Weiqiu Dong to the board

Mr. Lewis brings broad biopharmaceutical industry experience to the development and execution of PGDx’s growth strategy.

Before joining PGDx, Mr. Lewis served as Vice President, Business Development at Esperance Pharmaceuticals, a clinical stage oncology company, where he led strategic partnering and fundraising initiatives.

During this time, he also served as a business consultant and advisor to a diverse group of emerging life science companies.

Previously, at Astra Zeneca, he led business development activities for the cardiovascular franchise and was on the Crestor commercial team.

Prior to Astra Zeneca, Mr. Lewis held senior leadership positions in corporate strategy, business development and commercial operations at Biosyn, ViroPharma, and TAP Pharmaceuticals.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy